RUNX2 and colorectal adenocarcinoma: Zhuo et al. revealed that LINC01638 expression was obviously increased in colorectal adenocarcinoma patients while LINC01638 silencing repressed cell proliferation of colorectal adenocarcinoma through interaction with RUNX2 [12].